Promoting linear growth when treating child wasting
This article discusses the state of evidence surrounding the treatment of wasted and stunted children considering current challenges and possible solutions.
Natasha Lelijveld is a Senior Nutritionist at ENN
Kevin Stephenson is a Research Fellow at Washington University in St Louis
Mark Manary is a Professor at Washington University in St Louis
- Evidence suggests that children in wasting treatment are often stunted and they often become even more stunted during treatment and the post-discharge period.
- More research is needed to explore how wasting treatment programmes can better support linear growth and related functional outcomes.
- Current options for exploration include altering the composition and dose of ready-to-use food to contain more growth-promoting amino acids and the provision of better post-discharge support, since linear growth and development takes time to achieve.
Wasted children are more likely to be stunted and vice versa. Wasting and stunting are both markers for, and drivers of, adverse outcomes throughout childhood, negatively impacting cognitive development and increasing the risk of morbidity and mortality due to infectious diseases, as well as of obesity and other metabolic complications in later life (Grey et al, 2021). Wasting treatment currently targets short-term outcomes including survival and weight gain. However, given the interrelated risks associated with wasting and stunting, treatment approaches may have the potential to simultaneously enhance linear growth in addition.
Over the past few decades, successful, multisector interventions to prevent stunting have been identified and the prevalence of stunting has reduced globally, albeit slowly (Hossain et al, 2017). Current evidence suggests that effective strategies for stunting reduction focus on preventing (rather than treating or reversing) linear growth retardation during the first 1,000 days of life (Leroy et al, 2020). Well-evidenced preventative interventions include micronutrient supplementation during pregnancy and early childhood, breastfeeding promotion, complementary feeding education and complementary food supplementation such as regular small-quantity lipid nutrient supplements (Keats et al, 2021).
While stunting prevention should be prioritised, evidence also supports a biological plausibility for reversing stunting at the individual level. For example, adopted children who have experienced positive changes to their living environments have shown accelerated catch-up growth by aged 12 years (Johnson et al, 2018). Unfortunately, studies suggest that providing energy-dense and micronutrient-rich supplemental foods alone does not meaningfully support catch-up in height-for-age and more is needed to help children to achieve their growth potential (Dewey, 2016).
Linear growth during treatment for wasting
Survivors of severe wasting treatment are significantly more stunted than other stunted children in their community in the short- and long-term, regardless of how stunted they were at admission to treatment (Lelijveld et al, 2016). This suggests that children’s height-for-age declines while receiving treatment for wasting. The lack of adequate, subsequent catch-up growth also implies that the effects of wasting linger even after anthropometric ‘recovery’ is achieved. Alternative approaches to wasting treatment are needed that reduce the risk of stunting during recovery from wasting and, ideally, support catch-up in linear growth and development.
Route forward: Better supplementation?
One possible route forward is more targeted and comprehensive supplementation which specifically influences the biological drivers of growth. Evidence shows that essential amino acids regulate a complex set of molecular pathways involving a central signalling node (mTORC1) and the growth hormone IGF-1. These work together to control growth by promoting tissue building and preventing tissue breakdown (Semba et al, 2016; Valvezan & Manning, 2019). Without key amino acids, mTORC1 cannot be activated (Peterson et al, 2011). Stunted children have lower levels of all essential amino acids and likely require higher levels than many non-stunted children due to the need for catch-up growth. Animal-source foods are the richest sources of essential amino acids but are often lacking in the diets of children from countries with high burdens of stunting (Dror & Allen, 2011).
Greater availability of amino acids is also needed to fight systemic inflammation which often affects wasted and stunted children (Maleta et al, 2021). Targeting the various causes of inflammation in stunted children may also be essential for its reversal. While such avenues provide opportunities for reversing linear growth faltering, it is important to note that catch-up in linear growth does not necessarily reflect recovery in other domains, such as brain development, structure and function (Mackes et al, 2020). However, improved amino acid supplementation and the control of inflammation provide potential hypotheses for how wasting treatment can contribute to the prevention and reversal of stunting, ideally with subsequent functional implications.
Altering the composition and dose of ready-to-use food (RUF) might be important for promoting linear growth during and after wasting treatment. Providing milk-containing RUFs has been consistently associated with improved weight gain but less consistently with gain in length (Potani et al, 2021). The IGF-1 promoting effect of dairy has been proposed as a possible mechanism underlying this finding, while it is also possible the improved amino acid content might play a role through mTORC1. Dosage of RUF may also be important for linear growth, since wasting studies that have explored a reduced dosage regime have seen similar weight gain to the current dosage regime but reduced linear growth velocity (Kangas et al, 2019). In two studies, the rates of weight gain and recovery were similar in the standard dose and reduced dose groups, suggesting that the reduction in linear growth velocity may result from inadequacies in specific nutrients rather than insufficient wasting treatment (Stephenson et al, 2021). Identifying which nutrients are implicated could contribute to a better understanding of what causes declines in height-for-age z-scores after wasting recovery.
Route forward: Better post-discharge care?
In addition to maximising the formulation and dosage of RUF, post-discharge care following wasting treatment may mitigate the extent of further stunting. Wasting treatment is usually provided for a relatively short period (maximum 16 weeks) until adequate weight gain is achieved. Adequate weight is a prerequisite for linear growth attainment (Isanaka et al, 2019). Therefore, continuing wasting support beyond adequate weight gain may support linear growth and other longer-term outcomes. We know that current post-discharge care is inadequate with high rates of post-discharge mortality and relapse observed in many settings (Stobaugh et al, 2019; O’Sullivan et al, 2018). We also know that children are not immunologically recovered at discharge from wasting care, even if they have achieved adequate weight gain (Njunge et al, 2020). While the evidence for post-discharge vulnerability in severe wasting survivors is strong, very few studies have explored the impact of post-discharge interventions (Noble et al, 2021). The limited data available suggest that providing antibiotics, prebiotics/synbiotics, and/or psychosocial stimulation post-discharge may be beneficial for growth, survival and development. Post-discharge food supplementation and cash transfers may also reduce relapse (Mengesha et al, 2016; Grellety et al, 2017). These interventions have the potential to support long-term growth and development in wasting survivors. However, more robust and large-scale trials are needed.
Wasting and stunting have interrelated risk factors and an episode of wasting, even with treatment, can exacerbate stunting in the short-term and fail to support adequate catch-up growth in the longer-term. Current evidence suggests that optimising RUF formulations, especially those with adequate essential amino acids to activate biological growth pathways, optimising RUF dosage, increasing the intake of animal-source foods and better post-discharge support may contribute to optimal linear growth in children who survive wasting. However, this research is in its infancy and further exploration into optimal strategies that simultaneously target wasting and stunting is needed. Better still, more effective prevention strategies for wasting and stunting are needed.
Dewey, KG (2016) Reducing stunting by improving maternal, infant and young child nutrition in regions such as South Asia: Evidence, challenges and opportunities. Maternal & child nutrition, 12, 27-38.
Dror, DK and Allen, LH (2011) The importance of milk and other animal-source foods for children in low-income countries. Food and nutrition bulletin, 32, 227-243.
Grellety, E, Babakazo, P, Bangana, A, Mwamba, G, Lezama, I, Zagre, N et al (2017) Effects of unconditional cash transfers on the outcome of treatment for severe acute malnutrition: A cluster-randomised trial in the Democratic Republic of the Congo. BMC medicine, 15, 1-19.
Grey, K, Gonzales, GB, Abera, M, Lelijveld, N, Thompson D, Berhane, M et al (2021) Severe malnutrition or famine exposure in childhood and cardiometabolic non-communicable disease later in life: A systematic review. BMJ global health, 6, e003161.
Hossain, M, Choudhury, N, Abdullah, KaB, Mondal, P, Jackson, AA, Walson, J et al (2017) Evidence-based approaches to childhood stunting in low and middle income countries: A systematic review. Archives of Disease in Childhood, 102, 903-909.
Isanaka, S, Hitchings, MD, Berthé, F, Briend, A and Grais, RF (2019) Linear growth faltering and the role of weight attainment: Prospective analysis of young children recovering from severe wasting in Niger. Maternal & child nutrition, 15, e12817.
Johnson, DE, Tang, A, Almas, AN, Degnan, KA, Mclaughlin, KA, Nelson, CA et al (2018) Caregiving disruptions affect growth and pubertal development in early adolescence in institutionalized and fostered Romanian children: A randomized clinical trial. The Journal of pediatrics, 203, 345-353. e3.
Kangas, ST, Salpéteur, C, Nikièma, V, Talley, L, Ritz, C, Friis, H et al (2019) Impact of reduced dose of ready-to-use therapeutic foods in children with uncomplicated severe acute malnutrition: A randomised non-inferiority trial in Burkina Faso. PLoS medicine, 16, e1002887.
Keats, EC, Das, JK, Salam, RA, Lassi, ZS, Imdad, A, Black, RE et al (2021) Effective interventions to address maternal and child malnutrition: An update of the evidence. The Lancet Child & Adolescent Health.
Lelijveld, N, Seal, A, Wells, JC, Kirkby, J, Opondo, C, Chimwezi, E et al (2016) Chronic disease outcomes after severe acute malnutrition in Malawian children (Chrosam): A cohort study. The Lancet Global Health.
Leroy, JL, Frongillo, EA, Dewan, P, Black, MM and Waterland, RA (2020) Can children catch up from the consequences of undernourishment? Evidence from child linear growth, developmental epigenetics, and brain and neurocognitive development. Advances in Nutrition, 11, 1032-1041.
Mackes, NK, Golm, D, Sarkar, S, Kumsta, R, Rutter, M, Fairchild, G et al (2020) Early childhood deprivation is associated with alterations in adult brain structure despite subsequent environmental enrichment. Proceedings of the National Academy of Sciences, 117, 641-649.
Maleta, K, Fan, Y-M, Luoma, J, Ashorn, U, Bendabenda, J, Dewey, K et al (2021) Infections and systemic inflammation are associated with lower plasma concentration of insulin-like growth factor I among Malawian children. The American journal of clinical nutrition, 113, 380-390.
Mengesha, MM, Deyessa, N, Tegegne, BS and Dessie, Y (2016) Treatment outcome and factors affecting time to recovery in children with severe acute malnutrition treated at outpatient therapeutic care program. Global health action, 9, 30704.
Njunge, JM, Gonzales, GB, Ngari, MM, Thitiri, J, Bandsma, RH and Berkley, JA (2020) Systemic inflammation is negatively associated with early post discharge growth following acute illness among severely malnourished children-a pilot study. Wellcome Open Research, 5.
Noble, CC, Sturgeon, JP, Bwakura-Dangarembizi, M, Kelly, P, Amadi, B and Prendergast, AJ (2021) Postdischarge interventions for children hospitalized with severe acute malnutrition: A systematic review and meta-analysis. The American journal of clinical nutrition, 113, 574-585.
O’Sullivan, NP, Lelijveld, N, Rutishauser-Perera, A, Kerac, M and James, P (2018) Follow-up between 6 and 24 months after discharge from treatment for severe acute malnutrition in children aged 6-59 months: A systematic review. PloS one, 13, e0202053.
Peterson, TR, Sengupta, SS, Harris, TE, Carmack, AE, Kang, SA, Balderas, E et al (2011) Mtor complex 1 Regulates Lipin 1 Localization to Control the Srebp Pathway. Cell, 146, 408-420.
Potani, I, Spiegel-Feld, C, Brixi, G, Bendabenda, J, Siegfried, N, Bandsma, RH (2021) Ready-to-use therapeutic food (Rutf) containing low or no dairy compared to standard Rutf for children with severe acute malnutrition: A systematic review and meta-analysis. Advances in Nutrition.
Semba, RD, Trehan, I, Gonzalez-Freire, M, Kraemer, K, Moaddel, R, Ordiz, MI et al (2016) Perspective: The potential role of essential amino acids and the mechanistic target of rapamycin complex 1 (Mtorc1) pathway in the pathogenesis of child stunting. Advances in Nutrition, 7, 853-865.
Stephenson, KB, Agapova, SE, Hendrixson, DT, Koroma, AS and Manary, MJ (2021) An optimized dose of therapeutic feeding results in noninferior growth in midupper arm circumference compared with a standard dose in children in Sierra Leone recovering from acute malnutrition. Current developments in nutrition, 5, nzab007.
Stobaugh, HC, Mayberry, A, Mcgrath, M, Bahwere, P, Zagre, NM, Manary, MJ et al (2019) Relapse after severe acute malnutrition: A systematic literature review and secondary data analysis. Maternal & child nutrition, 15, e12702.
Valvezan, AJ and Manning, BD (2019) Molecular logic of Mtorc1 signalling as a metabolic rheostat. Nature Metabolism, 1, 321-333.
More like this
Summary of research1 Location: Global What we know: RUTF is as effective as F100 in treating SAM, where weight gain is the recovery outcome. Food supplements for moderate...
View this article as a pdf This article was written by Susan Thurstans, PhD candidate at the London School of Hygiene and Tropical Medicine and consultant to ENN on the...
Summary of meetinga The World Health Organisation (WHO) convened a meeting in Geneva (September 30th - October 3rd, 2008) with the overall aim of answering the question, 'What...
Summary of research* Location: Global. What we know: There is global momentum to bring down levels of undernutrition. Wasting and stunting frequently co-exist, but are often...
View this article as a pdf This article provides a summary of the Lancet Maternal & Child Nutrition Series to date, reflecting upon the 2021 series from the perspective of the...
Summary of published research1 Location: Africa, Asia, Latin America What we know already: Wasting and stunting are respectively short term and longer term conditions of...
View this article as a pdf This is a summary of the following paper: Odei Obeng-Amoako G, Stobaugh H, Wrottesley S et al (2023) How do children with severe underweight and...
View this article as a pdf Lisez cet article en français ici By Kevin PQ Phelan Kevin PQ Phelan is Nutrition Advisor at ALIMA, the Alliance for International Medical...
View this article as a pdf Nisha Kamble is an Occupational Therapist working with the State Centre of Excellence in Paediatric Nutrition at the B.J. Wadia Hospital for...
Published research1 Research was conducted between May 1998 and January 1999 at Saharawi refugee camps near the town of Tindouf in south west Algeria. After political changes...
FEX: Response to malnutrition treatment in low weight-for-age children: secondary analyses of ComPAS trial data
View this article as a pdf Research summary1 Location: Kenya and South Sudan What we know: Children who are concurrently wasted and stunted (WaSt) have a very high mortality...
Summary of research1 Location: Malawi What we know: There are limited data on long term outcomes following discharge from SAM treatment; what exists is largely pre-HIV....
FEX: En-net summary
View this article as a pdf En-net1 is a free, open resource for frontline nutrition practitioners to gain access to prompt technical advice for operational challenges where...
Summary of research* Location: Malawi What we know: Little is known about the long-term health effects of survivors of severe acute malnutrition (SAM), particularly risk of...
This is a little off topic but I am hoping that someone here might know the answer I've read in various places that stunting as a result of nutritional deprivation is...
en-net: What is the proper micronutrient composition for supplementation to promote catch up growth in stunted children?
According to DHS 2005 of Ethiopia, prevalence of stunting and wasting are 51% and 12%, respectively, showing that both malnutrition should not be neglected. So we are planning...
View this article as a pdf This article is a summary of the Research Agenda Revisited published by the No Wasted Lives Secretariat and the Council of Research Technical Advice...
View this article as a pdf Research snapshot1 Despite broad understanding that severe acute malnutrition (SAM) and disability can cause and influence one another, there is...
FEX: Effect of adding RUSF to ageneral food distribution on child nutritional status and morbidity: a cluster randomised controlled trial
Summary of research1 Child during appetite test at a health facility offering treatment in Monrovia, Liberia The authors of a recent study hypothesized that including a daily...
View this article as a pdf Lisez cet article en français ici By Merry Fitzpatrick, Gerard Bryan Gonzales, Alexandra Rutishauser-Perera and André Briend Merry...
Reference this page
Natasha Lelijveld, Kevin Stephenson and Mark Manary (). Promoting linear growth when treating child wasting. Field Exchange 67, April 2022. p70. www.ennonline.net/fex/67/viewspromotinglineargrowth